Literature DB >> 10416745

The role of age and cardiovascular disease in glaucomatous optic neuropathy.

S S Hayreh1.   

Abstract

The role of systemic cardiovascular disorders in glaucomatous optic neuropathy was studied experimentally in rhesus monkeys and clinically in humans. These studies suggest that, in the multifactorial phenomenon of glaucomatous optic neuropathy, among other risk factors, age, cardiovascular disease and nocturnal arterial hypotension may play an important role in the development and progression of glaucomatous optic neuropathy in many cases, independent of intraocular pressure. In glaucomatous optic neuropathy, age may be an indirect index of cardiovascular disease rather than an independent factor per se. Nocturnal arterial hypotension, particularly among hypertensive patients taking oral hypotensive medication, may be an important risk factor. Because 24-hour ambulatory blood pressure monitoring is becoming popular among ophthalmic researchers, multiple confounding factors in ambulatory blood pressure monitoring in patients with optic nerve head ischemic disorders that can produce misleading information are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10416745     DOI: 10.1016/s0039-6257(99)00018-1

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  25 in total

1.  Coincidence of normal tension glaucoma, progressive sensorineural hearing loss, and elevated antiphosphatidylserine antibodies.

Authors:  S Kremmer; E Kreuzfelder; E Bachor; K Jahnke; J M Selbach; S Seidahmadi
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

Review 2.  A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies.

Authors:  N N Osborne; G Lascaratos; A J Bron; G Chidlow; J P M Wood
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

3.  Individual molecular response to elevated intraocular pressure in perfused postmortem human eyes.

Authors:  Núria Comes; Teresa Borrás
Journal:  Physiol Genomics       Date:  2009-04-28       Impact factor: 3.107

4.  Cerebrospinal fluid pressure and glaucomatous optic disc cupping.

Authors:  Sohan Singh Hayreh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-06       Impact factor: 3.117

Review 5.  Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.

Authors:  Chihiro Mayama; Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2013-01-16       Impact factor: 2.447

6.  [Glaucoma and ocular hypertension in primary care].

Authors:  J Jaén Díaz; I Sanz Alcolea; F López De Castro; T Pérez Martínez; P Ortega Campos; R Corral Morales
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

Review 7.  Positioning patients for spine surgery: Avoiding uncommon position-related complications.

Authors:  Ihab Kamel; Rodger Barnette
Journal:  World J Orthop       Date:  2014-09-18

8.  Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram.

Authors:  Benedetto Falsini; Dario Marangoni; Tommaso Salgarello; Giovanna Stifano; Lucrezia Montrone; Salvatore Di Landro; Laura Guccione; Emilio Balestrazzi; Alberto Colotto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-17       Impact factor: 3.117

9.  Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.

Authors:  Kazuyuki Hirooka; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2007-09

Review 10.  Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis.

Authors:  H E Killer; A Pircher
Journal:  Eye (Lond)       Date:  2018-02-19       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.